People: Depomed Inc (DEPO.O)
DEPO.O on Nasdaq
5.79USD
23 May 2013
5.79USD
23 May 2013
Price Change (% chg)
$0.08 (+1.40%)
$0.08 (+1.40%)
Prev Close
$5.71
$5.71
Open
$5.71
$5.71
Day's High
$5.82
$5.82
Day's Low
$5.65
$5.65
Volume
404,760
404,760
Avg. Vol
567,257
567,257
52-wk High
$7.15
$7.15
52-wk Low
$4.75
$4.75
Moretti, August
Brief Biography
Mr. August J. Moretti serves as Chief Financial Officer, Senior Vice President of Depomed Inc., since January 2012. From 2004 to December 2011 he was Chief Financial Officer and Senior Vice President of Alexza Pharmaceuticals, Inc., a publicly held pharmaceutical company. From 2001 to 2004, Mr. Moretti was Chief Financial Officer of Alavita, Inc. (formerly Surromed, Inc.), a privately held biotechnology company. Prior to Alavita, he was a member of Heller Ehrman LLP, an international law firm. Mr. Moretti received a J.D. from Harvard Law School and a B.A. in economics from Princeton University.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Peter Staple |
-- |
James Schoeneck |
3,287,210 |
August Moretti |
-- |
Matthew Gosling |
924,312 |
Thadd Vargas |
734,307 |
Michael Sweeney |
814,297 |
As Of 30 Dec 2011

